367 results
8-K
91y 11fbo
14 Nov 23
Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
12:00am
8-K
cp7n6cd7zi0k9cc6h3
5 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
EX-1.1
8xk0qffs
30 Nov 22
Alaunos Therapeutics Announces Proposed Public Offering of Common Stock
5:10pm